NanoCure changes name to Avidimer Therapeutics

May 17, 2005 — The biopharmaceutical startup NanoCure Corp. changed its name today to Avidimer Therapeutics Inc. The name partially reflects the company’s use of dendrimers, novel branch-like polymers it uses to target diseased cells. Potential applications include diagnosis and treatment cancer and other diseases.

The company was formed in 2003 in Ann Arbor, Mich., based on intellectual property discovered and developed by the University of Michigan. Its first product candidate, ATI-001, is expected to enter human clinical trials in 2006.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.